Healthcare Triangle, Inc.
HCTI
$2.42
$0.146.14%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 19.24% | -9.86% | -68.98% | -68.98% | -65.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 19.24% | -9.86% | -68.98% | -68.98% | -65.00% |
| Cost of Revenue | 46.88% | 9.05% | -65.03% | -72.15% | -68.29% |
| Gross Profit | -44.99% | -67.55% | -83.27% | -57.70% | -53.88% |
| SG&A Expenses | 17.13% | -23.89% | -28.71% | -44.38% | -41.81% |
| Depreciation & Amortization | -- | -97.76% | 36.25% | -51.83% | -33.42% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.72% | -12.37% | -59.98% | -61.52% | -56.90% |
| Operating Income | 1.38% | 18.39% | -245.19% | 23.43% | 13.61% |
| Income Before Tax | 9.34% | 8.70% | 19.62% | 35.69% | 15.27% |
| Income Tax Expenses | -- | -- | -42.86% | -50.00% | -80.00% |
| Earnings from Continuing Operations | 9.40% | 8.70% | 19.71% | 35.72% | 15.45% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 9.40% | 8.70% | 19.71% | 35.72% | 15.45% |
| EBIT | 1.38% | 18.39% | -245.19% | 23.43% | 13.61% |
| EBITDA | -11.12% | -17.76% | -105.32% | -1.73% | -53.84% |
| EPS Basic | 99.17% | 58.68% | 43.66% | 51.47% | 32.05% |
| Normalized Basic EPS | 99.17% | 58.68% | -2,582.21% | 51.45% | 31.90% |
| EPS Diluted | 99.17% | 58.68% | 43.66% | 51.47% | 32.05% |
| Normalized Diluted EPS | 99.17% | 58.68% | -2,582.21% | 51.45% | 31.90% |
| Average Basic Shares Outstanding | 10,850.47% | 120.67% | 42.50% | 32.56% | 24.42% |
| Average Diluted Shares Outstanding | 10,850.47% | 120.67% | 42.50% | 32.56% | 24.42% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |